These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 14169785)

  • 21. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
    MCNICOL GP; DOUGLAS AS
    Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764
    [No Abstract]   [Full Text] [Related]  

  • 22. [THE USE OF EPSILON-AMINOCAPROIC ACID IN SURGICAL DISEASES].
    LECHTENBERG HW
    Munch Med Wochenschr; 1964 Mar; 106():615-7. PubMed ID: 14176552
    [No Abstract]   [Full Text] [Related]  

  • 23. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 24. [APROPOS OF THE CONTROL OF FIBRINOLYSIS DURING EXTRACORPOREAL CIRCULATION].
    MASCART P
    Acta Chir Belg; 1963 Sep; 62():677-81. PubMed ID: 14089252
    [No Abstract]   [Full Text] [Related]  

  • 25. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 26. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
    PERLICK E
    Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146
    [No Abstract]   [Full Text] [Related]  

  • 27. The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).
    Sinclair J; Forbes CD; Prentice CR; Scott R
    Urol Res; 1976 Nov; 4(3):129-31. PubMed ID: 797086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [FIBRINOLYSIS IN EXTRACORPOREAL CIRCULATION; ITS CAUSE AND TREATMENT].
    SUNADA T; SHIMIZU H; KAWAI S; KITAMURA H; MORIMOTO S; SHIGEMOTO H; TSUDA K; ONO I; NAKAYA R
    Rinsho Geka; 1964 Feb; 19():178-84. PubMed ID: 14135265
    [No Abstract]   [Full Text] [Related]  

  • 29. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
    BRODSKY I; ROSS E; REID WO
    Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048
    [No Abstract]   [Full Text] [Related]  

  • 30. STUDIES ON EFFECT OF STREPTOKINASE INFUSIONS IN THROMBOEMBOLIC DISEASE.
    OLOW B
    Acta Chir Scand; 1963; 126():7-23. PubMed ID: 14059874
    [No Abstract]   [Full Text] [Related]  

  • 31. [ON THE MODE OF ACTION OF EPSILON-AMINOCAPROIC ACID].
    RITZEL G; WUETHRICH R
    Schweiz Med Wochenschr; 1964 Feb; 94():267-71. PubMed ID: 14153727
    [No Abstract]   [Full Text] [Related]  

  • 32. [APROPOS OF A COMPLEX HEMORRHAGIC SYNDROME TREATED WITH EPSILON-AMINOCAPROIC ACID].
    CROIZAT P; REVOL L; THOUVEREZ ; BELLEVILLE ; BRUNAT
    Lyon Med; 1964 Feb; 211():403-9. PubMed ID: 14141971
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate.
    Lambert CJ; Marengo-Rowe AJ; Leveson JE; Green RH; Thiele JP; Geisler GF; Adam M; Mitchel BF
    Ann Thorac Surg; 1979 Nov; 28(5):440-4. PubMed ID: 496496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombosis with epsilon aminocaproic acid therapy.
    Gralnick HR; Greipp P
    Am J Clin Pathol; 1971 Aug; 56(2):151-4. PubMed ID: 5567720
    [No Abstract]   [Full Text] [Related]  

  • 35. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS].
    OPPELT HG; BECK L
    Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of postprostatectomy bleeding by epsilon-aminocaproic acid.
    Sack E; Spaet TH; Gentile RL; Hudson PB
    N Engl J Med; 1962 Mar; 266():541-3. PubMed ID: 14495863
    [No Abstract]   [Full Text] [Related]  

  • 37. [AN EFFECTIVE ANTIFIBRINOLYTIC AGENT: EPSILON-AMINOCAPROIC ACID].
    GROSSI F
    Clin Ter; 1963 Jul; 26():73-8. PubMed ID: 14050038
    [No Abstract]   [Full Text] [Related]  

  • 38. [THE ROLE OF EPSILON-AMINOCAPROIC ACID IN FIBRINOLYTIC STATES].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M; CASUBOLO L
    Rev Clin Esp; 1964 Oct; 95():17-21. PubMed ID: 14234364
    [No Abstract]   [Full Text] [Related]  

  • 39. [EPSILON-AMINOCAPROIC ACID: PRELIMINARY THERAPEUTIC RESULTS IN CERTAIN HEMORRHAGIC SYNDROMES].
    GUIMBRETIERE J; LEBEAUPIN PR
    Anesth Analg (Paris); 1964; 21():339-44. PubMed ID: 14156535
    [No Abstract]   [Full Text] [Related]  

  • 40. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW; NILSSON IM
    Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.